<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02960945</url>
  </required_header>
  <id_info>
    <org_study_id>CP543.1002</org_study_id>
    <nct_id>NCT02960945</nct_id>
  </id_info>
  <brief_title>Open-Label Crossover Study Comparing CTP-543 to Jakafi®</brief_title>
  <official_title>An Open-Label Single-Dose Crossover Pharmacokinetic Study to Compare CTP-543 to Jakafi® in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Concert Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Concert Pharmaceuticals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess the metabolite and pharmacokinetic (PK) profile of a single dose of
      CTP-543 compared to a single dose of Jakafi® in healthy volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The crossover design will assess the safety, tolerability, PK and metabolite profiles of a
      single dose of CTP-543 compared to a single dose of Jakafi. Approximately 12 healthy
      volunteers will be enrolled in this open label study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">January 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of CTP-543 metabolites and exposure in plasma under fasted conditions</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Adverse Events as a Measure of Safety and Tolerability</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of CTP-543 metabolites and exposure in urine under fasted conditions</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>CTP-543</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tablet, single oral dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Jakafi</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tablet, single oral dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CTP-543, 16 mg (2 x 8 mg tablet)</intervention_name>
    <arm_group_label>CTP-543</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Jakafi 15Mg Tablet</intervention_name>
    <arm_group_label>Jakafi</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adult males and females between 18 and 50 years of age, inclusive

          -  Body weight ≥ 50 kg and BMI within the range of 18 to 30 kg/m2, inclusive

        Exclusion Criteria:

          -  History of clinically significant central nervous system (eg, seizures), cardiac,
             pulmonary, metabolic, renal, hepatic, or gastrointestinal (GI) conditions

          -  PR interval &gt; 220 msec or QRS duration &gt; 120 msec or QTcF interval &gt; 450 msec obtained
             at screening visit or prior to the first dose of study drug

          -  History of herpes zoster

          -  Hemoglobin, white blood cell, or platelet levels below the lower reference limit at
             screening or prior to the first dose of study drug

          -  Liver function tests greater than the upper limit of normal

          -  Positive blood screen for human immunodeficiency virus (HIV antibody), hepatitis B
             virus surface antigen, or hepatitis C virus antibody

          -  Urinalysis positive for protein or glucose

          -  A positive screen for alcohol, drugs of abuse, or tobacco use

          -  Donation of blood, plasma or other blood products prior to screening

          -  A positive tuberculosis test
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 8, 2016</study_first_submitted>
  <study_first_submitted_qc>November 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 10, 2016</study_first_posted>
  <last_update_submitted>March 27, 2017</last_update_submitted>
  <last_update_submitted_qc>March 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

